Company information
- Ticker
- BHIC
- Country
- United States
- Sector
- Health Care
- Industry
- Pharma
BioScience Health Innovations Business Summary
BioScience Health Innovations, Inc. (BHIC) operates as a diversified health sciences company primarily generating revenue through the distribution and direct-to-consumer (DTC) sale of clinically tested nutraceuticals and wellness products. The company’s business model is centered on its subsidiary, Best 365 Labs, which utilizes a proprietary Mineral Oxide Delivery System (MODS Max) platform to enhance the absorption and stability of its formulations. BHIC’s primary business segments include immune health (Be-OnGuard nasal and mouth sprays), cognitive performance (ADHD 365 and Brain Fog Support utilizing pharmaceutical-grade methylene blue), and metabolic wellness (Metabolism+). The company leverages high-traffic online retail channels, including Amazon and its dedicated e-commerce platform, to capture market share in the rapidly expanding preventive health sector. BHIC competes directly with established players such as Thorne HealthTech, Hims & Hers Health, and Onnit Labs, positioning itself as a technology-forward alternative that bridges the gap between traditional dietary supplements and advanced transmucosal drug delivery systems. Leadership at BHIC is anchored by a founding team with extensive experience in the nutraceutical and medical device industries. Chief Executive Officer Darren Lopez, MBA, brings over 23 years of entrepreneurial expertise in anti-aging and wellness, having previously founded Ageless Enterprises and served in executive roles at That Marketing Solution, Inc. Chief Technology Officer Dan Schmidt contributes over 26 years of experience in therapeutic medical devices, including radio frequency and laser technologies, focusing on the commercialization of innovative healthcare products. The executive team is rounded out by CFO John Chymboryk, a 30-year financial veteran who oversees the company’s fiscal strategy and public reporting. The Board of Directors includes Lopez, Chymboryk, and Independent Director Justin Earl. Following its 2025 rebranding from Nowtransit Inc., the company has focused on securing its intellectual property portfolio, which currently includes six pending patents related to its MODS Max delivery platform.